# The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy

> **NCT06514586** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Oxagon** · enrollment: 244 (estimated)

## Conditions studied

- Vaginal Atrophy
- Genitourinary Syndrome of Menopause
- Vulvar Atrophy

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Hydroxypropyl methylcellulose

## Key facts

- **NCT ID:** NCT06514586
- **Lead sponsor:** Oxagon
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-06
- **Final completion:** 2025-08
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514586, "The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06514586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*